Publications by authors named "Shyamal Kumar Mukherjee"
Context: Nocturnal enuresis (NE) is a very common problem in childhood. The prevalence rate varies from 3.5% to 56.
View Article and Find Full Text PDFIndividualized Homeopathic Medicinal Products in the Treatment of Post-COVID-19 Conditions: A Double-Blind, Randomized, Placebo-Controlled, Feasibility Trial.
J Integr Complement Med
September 2024
Article Synopsis
- A study investigated the effectiveness of individualized homeopathic medicinal products (IHMPs) compared to placebos for improving health-related quality of life in individuals suffering from post-COVID-19 conditions, with up to 80% of infected individuals experiencing ongoing symptoms.* -
- Conducted at a medical college in India, the trial involved 60 participants divided into two groups: one receiving IHMPs plus care and the other receiving placebos plus care. The study tracked health outcomes over three months using established assessment tools.* -
- Results showed that IHMPs significantly outperformed placebos in reducing post-COVID-19 symptoms, with notable improvements in both primary and secondary outcome measures, suggesting promise for homeopathic treatments in future
Prevalence of irregular menstrual cycle ranges from 81.7% to 96.3%.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to systematically investigate symptoms associated with commonly prescribed homeopathic medicines using Bayesian statistics for more accurate likelihood ratios (LR).
- Conducted over 21 months with 1,954 patients, the research utilized the ORIDL scale to measure treatment outcomes and calculated LRs for four specific symptoms linked to six selected homeopathic remedies.
- Findings revealed high LR+ scores for symptoms like "dyspepsia from business anxiety" and "burning pain relieved by heat," supporting existing homeopathic literature, but emphasized the need for further research to confirm results in larger populations.
Individualized homeopathic medicines in preventing the progression from pre-diabetes to diabetes: A double-blind, randomized, placebo-controlled, parallel-arm trial.
Explore (NY)
September 2024
Context: Pre-diabetes is a significant public health problem worldwide. India has a very high rate of progression from pre-diabetes to diabetes, 75-78 per thousand persons per year.
Objective: To study the efficacy of individualized homeopathic medicinal products (HMPs) against placebos in preventing the progression from pre-diabetes to diabetes.
Introduction: Hyperuricemia (HU) is a major health issue in India and across the globe. It increases the disease burden and hampers quality of life. This study was aimed at exploring the effects of individualized homeopathic medicines (IHMs) against placebo in the treatment of HU.
View Article and Find Full Text PDFIntroduction: There is some evidence that homeopathic treatment has been used successfully in previous epidemics, and currently some countries are testing homeoprophylaxis for the coronavirus disease 2019 (COVID-19) pandemic. There is a strong tradition of homeopathic treatment in India: therefore, we decided to compare three different homeopathic medicines against placebo in prevention of COVID-19 infections.
Methods: In this double-blind, cluster-randomized, placebo-controlled, four parallel arms, community-based, clinical trial, a 20,000-person sample of the population residing in Ward Number 57 of the Tangra area, Kolkata, was randomized in a 1:1:1:1 ratio of clusters to receive one of three homeopathic medicines ( 30cH, 30cH, 30cH) or identical-looking placebo, for 3 (children) or 6 (adults) days.
Context: Pre-hypertension remains a significant public health challenge and appropriate intervention is required to stop its progression to hypertension and/or cardiovascular diseases.
Objective: To study the effects of individualized homeopathic medicines (IH) against placebo in intervening with the progression of pre-hypertension to hypertension.
Design: Double-blind, randomized, two parallel arms, placebo-controlled trial.